New York, December 27, 2025 – Artificial intelligence is poised to dramatically reshape colorectal cancer (CRC) detection, possibly flagging high-risk individuals up to five years before customary methods would. This shift, alongside rising rates of the disease in younger adults and ongoing debates over access to screening, dominated colorectal cancer discussions this year.
AI-Powered Detection and a Changing Risk Landscape
Table of Contents
Breakthroughs in artificial intelligence and a concerning rise in early-onset cases are refocusing attention on colorectal cancer screening and prevention.
- An AI tool, “C the Signs,” showed 93.8% sensitivity in identifying CRC risk in a retrospective analysis of nearly 900,000 patient records.
- Biological age-how well the body functions-may be a more accurate predictor of CRC risk than chronological age.
- A Supreme Court case threatens to roll back access to free colorectal cancer screenings for millions of Americans.
- Rising rates of CRC in younger adults are prompting a reevaluation of screening guidelines.
- Lifestyle factors, including diet and gut health, are increasingly linked to early-onset CRC.
What’s the most effective way to reduce colorectal cancer risk? Regular screening, starting at age 45 for those at average risk, remains the cornerstone of prevention. Though, emerging research suggests that personalized approaches, incorporating biological age and AI-driven risk assessments, may soon become integral to early detection.
The Promise of Artificial Intelligence
The AI-based tool “C the Signs” demonstrated a remarkable ability to identify individuals at high risk for CRC years before conventional detection methods. The retrospective analysis, encompassing nearly 900,000 patient records, revealed a sensitivity of 93.8% in pinpointing CRC risk, offering a potentially transformative approach to early detection, notably for those without obvious risk factors or outside standard screening age brackets.
Biological Age: A New Risk Factor?
Emerging research suggests that biological age-a measure of the body’s functional state, rather than simply years lived-may be a more precise indicator of CRC risk. A study utilizing established biomarkers found that individuals with a biological age substantially exceeding their chronological age exhibited higher CRC prevalence, even after accounting for gender. This finding opens the door to the possibility of clinicians leveraging biological-aging metrics to identify high-risk individuals who might otherwise be overlooked by traditional age-based screening guidelines.
Threats to Screening Access
A legal challenge before the US Supreme Court raised concerns from the American College of Gastroenterology that millions of Americans could lose access to no-cost colorectal cancer screenings. The case centers on whether the court will uphold the screening recommendations issued by the US Preventive Services Task Force (USPSTF). If the court weakens
